首页> 美国卫生研究院文献>American Journal of Respiratory Cell and Molecular Biology >Nuclear Factor-κB Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion
【2h】

Nuclear Factor-κB Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion

机译:核因子-κB影响恶性胸腔积液小鼠模型中的肿瘤进展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We developed a novel mouse model of malignant pleural effusion (MPE) by injecting Lewis lung cancer (LLC) cells directly into the pleural space of syngeneic C57B/6 mice. The pleural effusions in this model share common cellular and biochemical features with human MPEs. Implantation and growth of pleural tumors triggers a host inflammatory response characterized by a mixed inflammatory cell influx into the pleural fluid. LLC cells exhibited high basal nuclear factor (NF)-κB activity in vitro and in vivo, which we used to drive expression of a NF-κB–dependent green fluorescent protein-firefly luciferase fusion reporter construct. NF-κB–dependent reporter expression allowed intravital tracing of pleural tumors. Inhibition of NF-κB in LLC cells did not affect cell viability in culture; however, injection of LLC cells expressing a dominant NF-κB inhibitor resulted in decreased tumor burden, decreased pleural effusion volume, and decreased pleural effusion TNF-α levels. These studies indicate that tumor NF-κB activity regulates pleural tumor progression. This reproducible model of MPE can be used to further study the influence of specific host and tumor factors on the pathogenesis of MPE and evaluate new therapeutic strategies.
机译:通过将Lewis肺癌(LLC)细胞直接注入同基因C57B / 6小鼠的胸膜空间,我们开发了一种新型的恶性胸腔积液(MPE)小鼠模型。该模型中的胸腔积液与人MPE具有共同的细胞和生化特征。胸膜肿瘤的植入和生长触发了宿主炎症反应,其特征在于混合的炎症细胞流入胸膜液。 LLC细胞在体外和体内均表现出较高的基础核因子(NF)-κB活性,我们用它来驱动依赖NF-κB的绿色荧光蛋白-萤火虫荧光素酶融合报告基因构建体的表达。依赖NF-κB的报告基因表达可对胸膜肿瘤进行活体示踪。在LLC细胞中抑制NF-κB不会影响培养中的细胞活力。然而,注射表达显性NF-κB抑制剂的LLC细胞导致肿瘤负荷降低,胸腔积液量减少和胸腔积液TNF-α水平降低。这些研究表明肿瘤NF-κB活性调节胸膜肿瘤的进展。这种可重现的MPE模型可用于进一步研究特定宿主和肿瘤因素对MPE发病机理的影响,并评估新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号